Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate use of BI 10773 as add-on to insulin regimen alone or with metformin
in patients with typr 2 diabetes. Both lowering glucose and HbA1c and reducing the use of
insulin in this population would provide significant new information for the BI 10773 use and
would offer a potential new therapeutic option in this population.